{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:53:17Z","timestamp":1740135197811,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"S8","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62172028","61772197"],"award-info":[{"award-number":["62172028","61772197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Knowing the responses of a patient to drugs is essential to make personalized medicine practical. Since the current clinical drug response experiments are time-consuming and expensive, utilizing human genomic information and drug molecular characteristics to predict drug responses is of urgent importance. Although a variety of computational drug response prediction methods have been proposed, their effectiveness is still not satisfying.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we propose a method called LGRDRP (Learning Graph Representation for Drug Response Prediction) to predict cell line-drug responses. At first, LGRDRP constructs a heterogeneous network integrating multiple kinds of information: cell line miRNA expression profiles, drug chemical structure similarity, gene-gene interaction, cell line-gene interaction and known cell line-drug responses. Then, for each cell line, learning graph representation and Laplacian feature selection are combined to obtain network topology features related to the cell line. The learning graph representation method learns network topology structure features, and the Laplacian feature selection method further selects out some most important ones from them. Finally, LGRDRP trains an SVM model to predict drug responses based on the selected features of the known cell line-drug responses. Our five-fold cross-validation results show that LGRDRP is significantly superior to the art-of-the-state methods in the measures of the average area under the receiver operating characteristics curve, the average area under the precision-recall curve and the recall rate of top-<jats:italic>k<\/jats:italic> predicted sensitive cell lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results demonstrated that the usage of multiple types of information about cell lines and drugs, the learning graph representation method, and the Laplacian feature selection is useful to the improvement of performance in predicting drug responses. We believe that such an approach would be easily extended to similar problems such as miRNA-disease relationship inference.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-022-05080-4","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T11:03:07Z","timestamp":1670583787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug response prediction using graph representation learning and Laplacian feature selection"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-093X","authenticated-orcid":false,"given":"Minzhu","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"12","key":"5080_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/nbt.2877","volume":"32","author":"JC Costello","year":"2014","unstructured":"...Costello JC, Heiser LM, Georgii E, Gonen M, Menden MP, Wang NJ, Bansal M, Ammad-ud-din M, Hintsanen P, Khan SA, Mpindi JP, Kallioniemi O, Honkela A, Aittokallio T, Wennerberg K, Community ND, Collins JJ, Gallahan D, Singer D, Saez-Rodriguez J, Kaski S, Gray JW, Stolovitzky G. A community effort to assess and improve drug sensitivity prediction algorithms. Nat Biotechnol. 2014;32(12):1202\u201312. https:\/\/doi.org\/10.1038\/nbt.2877.","journal-title":"Nat Biotechnol"},{"issue":"7517","key":"5080_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/513S8a","volume":"513","author":"M Eisenstein","year":"2014","unstructured":"Eisenstein M. Personalized medicine: special treatment. Nature. 2014;513(7517):8\u20139. https:\/\/doi.org\/10.1038\/513S8a.","journal-title":"Nature"},{"issue":"6","key":"5080_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJMp1114866","volume":"366","author":"R Mirnezami","year":"2012","unstructured":"Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med. 2012;366(6):489\u201391. https:\/\/doi.org\/10.1056\/NEJMp1114866.","journal-title":"N Engl J Med"},{"issue":"Database issue","key":"5080_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, Ramaswamy S, Futreal PA, Haber DA, Stratton MR, Benes C, McDermott U, Garnett MJ. Genomics of drug sensitivity in cancer (gdsc): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):955\u201361. https:\/\/doi.org\/10.1093\/nar\/gks1111.","journal-title":"Nucleic Acids Res"},{"issue":"7391","key":"5080_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi JP, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603\u20137. https:\/\/doi.org\/10.1038\/nature11003.","journal-title":"Nature"},{"issue":"5","key":"5080_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/tpj.2011.35","volume":"12","author":"A Torkamani","year":"2012","unstructured":"Torkamani A, Schork NJ. Background gene expression networks significantly enhance drug response prediction by transcriptional profiling. Pharmacogenomics J. 2012;12(5):446\u201352. https:\/\/doi.org\/10.1038\/tpj.2011.35.","journal-title":"Pharmacogenomics J"},{"key":"5080_CR7","doi-asserted-by":"publisher","first-page":"23857","DOI":"10.1038\/srep23857","volume":"6","author":"S Gupta","year":"2016","unstructured":"Gupta S, Chaudhary K, Kumar R, Gautam A, Nanda JS, Dhanda SK, Brahmachari SK, Raghava GP. Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: a step towards personalized medicine. Sci Rep. 2016;6:23857. https:\/\/doi.org\/10.1038\/srep23857.","journal-title":"Sci Rep"},{"issue":"10","key":"5080_CR8","doi-asserted-by":"publisher","first-page":"0205155","DOI":"10.1371\/journal.pone.0205155","volume":"13","author":"Y Fang","year":"2018","unstructured":"Fang Y, Xu P, Yang J, Qin Y. A quantile regression forest based method to predict drug response and assess prediction reliability. PLoS One. 2018;13(10):0205155. https:\/\/doi.org\/10.1371\/journal.pone.0205155.","journal-title":"PLoS One"},{"key":"5080_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12885-015-1492-6","volume":"15","author":"ZL Dong","year":"2015","unstructured":"Dong ZL, Zhang NQ, Li C, Wang HY, Fang Y, Wang J, Zheng XQ. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection. BMC Cancer. 2015;15:489. https:\/\/doi.org\/10.1186\/s12885-015-1492-6.","journal-title":"BMC Cancer"},{"issue":"3","key":"5080_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox NJ, Huang RS. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 2014;15(3):47. https:\/\/doi.org\/10.1186\/gb-2014-15-3-r47.","journal-title":"Genome Biol"},{"key":"5080_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.omtn.2020.07.003","volume":"21","author":"CY Liu","year":"2020","unstructured":"Liu CY, Wei D, Xiang J, Ren FQ, Huang L, Lang JD, Tian G, Li YS, Yang JL. An improved anticancer drug-response prediction based on an ensemble method integrating matrix completion and ridge regression. Mol Ther Nucleic Acids. 2020;21:676\u201386. https:\/\/doi.org\/10.1016\/j.omtn.2020.07.003.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"5080_CR12","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1021\/ci500152b","volume":"54","author":"M Ammad-ud-din","year":"2014","unstructured":"Ammad-ud-din M, Georgii E, Gonen M, Laitinen T, Kallioniemi O, Wennerberg K, Poso A, Kaski S. Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization. J Chem Inf Model. 2014;54(8):2347\u201359. https:\/\/doi.org\/10.1021\/ci500152b.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"5080_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1109\/TCBB.2019.2919581","volume":"18","author":"M Li","year":"2021","unstructured":"Li M, Wang Y, Zheng R, Shi X, Li Y, Wu FX, Wang J. Deepdsc: a deep learning method to predict drug sensitivity of cancer cell lines. IEEE\/ACM Trans Comput Biol Bioinform. 2021;18(2):575\u201382. https:\/\/doi.org\/10.1109\/TCBB.2019.2919581.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"4","key":"5080_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.15302\/j-qb-021-0259","volume":"9","author":"XY Yan","year":"2021","unstructured":"Yan XY, Zhang SW, Yiu SM, Shi JY. Interpretable prediction of drug-cell line response by triple matrix factorization. Quantit Biol. 2021;9(4):426\u201339. https:\/\/doi.org\/10.15302\/j-qb-021-0259.","journal-title":"Quantit Biol"},{"key":"5080_CR15","doi-asserted-by":"publisher","DOI":"10.1109\/tcbb.2021.3065535","author":"B Guvenc Paltun","year":"2021","unstructured":"Guvenc Paltun B, Kaski S, Mamitsuka H. Diverse: Bayesian data integrative learning for precise drug response prediction. IEEE\/ACM Trans Comput Biol Bioinform. 2021. https:\/\/doi.org\/10.1109\/tcbb.2021.3065535.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"12","key":"5080_CR16","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2174\/138945012803530143","volume":"13","author":"CJ Creighton","year":"2012","unstructured":"Creighton CJ. Molecular classification and drug response prediction in cancer. Curr Drug Targets. 2012;13(12):1488\u201394. https:\/\/doi.org\/10.2174\/138945012803530143.","journal-title":"Curr Drug Targets"},{"key":"5080_CR17","doi-asserted-by":"publisher","first-page":"32679","DOI":"10.1038\/srep32679","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Fang J, Chen S. Inferences of drug responses in cancer cells from cancer genomic features and compound chemical and therapeutic properties. Sci Rep. 2016;6:32679. https:\/\/doi.org\/10.1038\/srep32679.","journal-title":"Sci Rep"},{"key":"5080_CR18","doi-asserted-by":"publisher","first-page":"40321","DOI":"10.1038\/srep40321","volume":"7","author":"Z Stanfield","year":"2017","unstructured":"Stanfield Z, Coskun M, Koyuturk M. Drug response prediction as a link prediction problem. Sci Rep. 2017;7:40321. https:\/\/doi.org\/10.1038\/srep40321.","journal-title":"Sci Rep"},{"issue":"1","key":"5080_CR19","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1038\/s41598-018-21622-4","volume":"8","author":"F Zhang","year":"2018","unstructured":"Zhang F, Wang M, Xi J, Yang J, Li A. A novel heterogeneous network-based method for drug response prediction in cancer cell lines. Sci Rep. 2018;8(1):3355. https:\/\/doi.org\/10.1038\/s41598-018-21622-4.","journal-title":"Sci Rep"},{"key":"5080_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.omtn.2018.09.011","volume":"13","author":"H Liu","year":"2018","unstructured":"Liu H, Zhao Y, Zhang L, Chen X. Anti-cancer drug response prediction using neighbor-based collaborative filtering with global effect removal. Mol Ther Nucleic Acids. 2018;13:303\u201311. https:\/\/doi.org\/10.1016\/j.omtn.2018.09.011.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5080_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3389\/fphar.2018.01017","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang L, Chen X, Guan NN, Liu H, Li JQ. A hybrid interpolation weighted collaborative filtering method for anti-cancer drug response prediction. Front Pharmacol. 2018;9:1017. https:\/\/doi.org\/10.3389\/fphar.2018.01017.","journal-title":"Front Pharmacol"},{"key":"5080_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.omtn.2019.05.017","volume":"17","author":"NN Guan","year":"2019","unstructured":"Guan NN, Zhao Y, Wang CC, Li JQ, Chen X, Piao X. Anticancer drug response prediction in cell lines using weighted graph regularized matrix factorization. Mol Ther Nucleic Acids. 2019;17:164\u201374. https:\/\/doi.org\/10.1016\/j.omtn.2019.05.017.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5080_CR23","doi-asserted-by":"publisher","unstructured":"Cao S, Lu W, Xu Q. Grarep: Learning graph representations with global structural information. In: Proceedings of the 24th ACM international on conference on information and knowledge management. New York, NY, United States: Association for Computing Machinery; 2015. pp. 891\u2013900. https:\/\/doi.org\/10.1145\/2806416.2806512.","DOI":"10.1145\/2806416.2806512"},{"key":"5080_CR24","doi-asserted-by":"publisher","DOI":"10.1145\/1961189.1961199","author":"CC Chang","year":"2011","unstructured":"Chang CC, Lin CJ. Libsvm: a library for support vector machines. Acm Trans Intell Syst Technol. 2011. https:\/\/doi.org\/10.1145\/1961189.1961199.","journal-title":"Acm Trans Intell Syst Technol"},{"issue":"6","key":"5080_CR25","doi-asserted-by":"publisher","first-page":"0218760","DOI":"10.1371\/journal.pone.0218760","volume":"14","author":"SE Awan","year":"2019","unstructured":"Awan SE, Bennamoun M, Sohel F, Sanfilippo FM, Chow BJ, Dwivedi G. Feature selection and transformation by machine learning reduce variable numbers and improve prediction for heart failure readmission or death. PLoS One. 2019;14(6):0218760. https:\/\/doi.org\/10.1371\/journal.pone.0218760.","journal-title":"PLoS One"},{"issue":"5\u20136","key":"5080_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/bfgp\/elaa013","volume":"19","author":"DH Le","year":"2020","unstructured":"Le DH. Machine learning-based approaches for disease gene prediction. Brief Funct Genomics. 2020;19(5\u20136):350\u201363. https:\/\/doi.org\/10.1093\/bfgp\/elaa013.","journal-title":"Brief Funct Genomics"},{"issue":"4","key":"5080_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/bib\/bbv066","volume":"17","author":"X Chen","year":"2016","unstructured":"Chen X, Yan CC, Zhang XT, Zhang X, Dai F, Yin J, Zhang YD. Drug-target interaction prediction: databases, web servers and computational models. Brief Bioinform. 2016;17(4):696\u2013712. https:\/\/doi.org\/10.1093\/bib\/bbv066.","journal-title":"Brief Bioinform"},{"issue":"2","key":"5080_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/bib\/bbx130","volume":"20","author":"X Chen","year":"2019","unstructured":"Chen X, Xie D, Zhao Q, You ZH. Micrornas and complex diseases: from experimental results to computational models. Brief Bioinform. 2019;20(2):515\u201339. https:\/\/doi.org\/10.1093\/bib\/bbx130.","journal-title":"Brief Bioinform"},{"issue":"7","key":"5080_CR29","doi-asserted-by":"publisher","first-page":"1004975","DOI":"10.1371\/journal.pcbi.1004975","volume":"12","author":"X Chen","year":"2016","unstructured":"Chen X, Ren B, Chen M, Wang Q, Zhang L, Yan G. Nllss: predicting synergistic drug combinations based on semi-supervised learning. Plos Comput Biol. 2016;12(7):1004975. https:\/\/doi.org\/10.1371\/journal.pcbi.1004975.","journal-title":"Plos Comput Biol."},{"key":"5080_CR30","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2147\/Ott.S193808","volume":"12","author":"CW Yu","year":"2019","unstructured":"Yu CW, Dai DJ, Xie J. Molecular subtype classification of papillary renal cell cancer using mirna expression. Oncotargets Therapy. 2019;12:2311\u201322. https:\/\/doi.org\/10.2147\/Ott.S193808.","journal-title":"Oncotargets Therapy"},{"key":"5080_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1471-2105-9-405","volume":"9","author":"S Razick","year":"2008","unstructured":"Razick S, Magklaras G, Donaldson IM. irefindex: a consolidated protein interaction database with provenance. BMC Bioinformatics. 2008;9:405. https:\/\/doi.org\/10.1186\/1471-2105-9-405.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"5080_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Goncalves E, Barthorpe S, Lightfoot H, Cokelaer T, Greninger P, van Dyk E, Chang H, de Silva H, Heyn H, Deng XM, Egan RK, Liu QS, Mironenko T, Mitropoulos X, Richardson L, Wang JH, Zhang TH, Moran S, Sayols S, Soleimani M, Tamborero D, Lopez-Bigas N, Ross-Macdonald P, Esteller M, Gray NS, Haber DA, Stratton MR, Benes CH, Wessels LFA, Saez-Rodriguez J, McDermott U, Garnett MJ. A landscape of pharmacogenomic interactions in cancer. Cell. 2016;166(3):740\u201354. https:\/\/doi.org\/10.1016\/j.cell.2016.06.017.","journal-title":"Cell"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-05080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-05080-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-05080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T11:03:42Z","timestamp":1670583822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-05080-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":32,"journal-issue":{"issue":"S8","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5080"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-05080-4","relation":{},"ISSN":["1471-2105"],"issn-type":[{"type":"electronic","value":"1471-2105"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"6 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}